As of 21 Nov 2024, Clinuvel Pharmaceuticals total assets is $131.05M, an increase of 34.57% to 2022. This figure includes all the resources and properties owned by Clinuvel Pharmaceuticals, reflecting its financial standing at that time.
Year | Total Assets | Change |
---|---|---|
2023 | $131.05M | 34.57% |
2022 | $97.39M | 32.59% |
2021 | $73.45M | 33.14% |
2020 | $55.17M | 30.79% |
2019 | $42.18M | - |